A History of Prior Bare Metal Stent Restenosis Is Associated with Major Adverse Cardiac Events in Subsequent Bare Metal Stenting of de novo Coronary Lesions

被引:2
|
作者
Ferguson, Michael A. [1 ]
Needleman, Matthew
Mitchell, Eric S. [2 ]
Carter, Luther I. [3 ]
Bustamante, Alexander I.
Love, Kathleen M. [3 ]
Curran, Michael J.
机构
[1] Natl Naval Med Ctr, Dept Cardiol, Bethesda, MD 20889 USA
[2] USN, Med Ctr, Portsmouth, VA USA
[3] USN, Med Ctr, San Diego, CA 92152 USA
关键词
Coronary lesion; Bare metal stent; Restenosis; Major adverse cardiac events; INTERVENTION;
D O I
10.1159/000319472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate the risk of major adverse cardiac events (MACE) in patients with a history of bare metal stent (BMS) restenosis who undergo subsequent bare metal stenting of a geographically distinct, de novo coronary lesion. Methods: We conducted a retrospective review of 72 BMS procedures performed in geographically distinct, de novo coronary lesions in patients with a history of previous BMS placement at least 3 months prior to the second, index stent procedure. Patients with a history of in-stent restenosis (ISR) were compared with those who had no ISR in their initial stent. Results: Restenosis in the initial BMS was associated with a significant increase in MACE after placement of the index BMS (OR 20.0, 95% CI 3.86-103.58, p < 0.0001). This association was independent of traditional clinical and angio-graphic risk factors for restenosis. Conclusions: Restenosis of a previously placed BMS is strongly associated with MACE after placement of a subsequent BMS in a de novo coronary lesion. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:190 / 193
页数:4
相关论文
共 50 条
  • [31] Correlation between hs-CRP and genetic polymorphism in in-stent-restenosis after bare metal stenting
    Chinikar, M.
    Sadeghipour, P.
    Javadi, S.
    Rafati, S.
    Heidarzadeh, A.
    Hoda, S.
    Taslimi, Y.
    Esmaili, H.
    EUROPEAN HEART JOURNAL, 2012, 33 : 706 - 707
  • [32] Coronary Angioscopy Findings before and after Excimer Laser Coronary Angioplasty for Bare-Metal Stent In-Stent Restenosis
    Masuda, Shinichiro
    Shibui, Takashi
    Nagamine, Sho
    Tsuchiyama, Takaaki
    Ashikaga, Takashi
    KOREAN CIRCULATION JOURNAL, 2019, 49 (05) : 461 - 463
  • [33] Retrospective Comparison of the Clinical and Angiographic Outcomes of the Sirolimus-eluting Stent and the Bare-metal Stent in 2031 Nonrandomized Consecutive De Novo Native Coronary Lesions
    Kubota, Takeyuki
    Ishikawa, Tetsuya
    Mutoh, Makoto
    INTERNAL MEDICINE, 2011, 50 (21) : 2463 - 2470
  • [34] The impact of postprocedural trimetazidine therapy on bare metal stent restenosis in patients undergoing percutaneous coronary intervention
    Canpolat, U.
    Yorgun, H.
    Coteli, C.
    Asil, S.
    Sahiner, L.
    Kaya, E. B.
    Kabakci, G.
    Tokgozoglu, L.
    Ozer, N.
    Aytemir, K.
    EUROPEAN HEART JOURNAL, 2016, 37 : 669 - 669
  • [35] Percutaneous Coronary Intervention Related Infarction Is a Predictor of Late In-Stent Restenosis in Bare Metal Stents
    Dickerson, Andrew G.
    Neeland, Ian J.
    Ahuja, Ayushi
    Patel, Riyaz
    Ozkor, Muhiddin
    Murrow, Jonathan
    Dhawan, Saurabh
    Samady, Habib
    Rab, S. Tanveer
    Douglas, John
    Morris, Douglas
    Zafari, A. Maziar
    Quyyumi, Arshed A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A332 - A332
  • [36] Systemic Rapamycin Without Loading Dose for Restenosis Prevention After Coronary Bare Metal Stent Implantation
    Stojkovic, Sinisa
    Ostojic, Miodrag
    Nedeljkovic, Milan
    Stankovic, Goran
    Beleslin, Branko
    Vukcevic, Vladan
    Orlic, Dejan
    Arandjelovic, Aleksandra
    Kostic, Jelena
    Dikic, Miodrag
    Tomasevic, Miloje
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 75 (03) : 317 - 325
  • [37] Red Cell Distribution Width and Neutrophil/Lymphocyte Ratio in Coronary Bare Metal Stent Restenosis.
    Yilmaz, Kerem Can
    Ciftci, Orcun
    Karacaglar, Emir
    Bal, Ugur Abbas
    Okyay, Kaan
    Aydinalp, Alp
    Yildirir, Aylin
    Muderrisoglu, Ibrahim Haldun
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (08): : E46 - E46
  • [38] A Polymer-Free Paclitaxel-Eluting Stent Versus a Bare-Metal Stent for De Novo Femoropopliteal Lesions The BATTLE Trial
    Goueffic, Yann
    Sauguet, Antoine
    Desgranges, Pascal
    Feugier, Patrick
    Rosset, Eugenio
    Ducasse, Eric
    Kaladji, Adrien
    du Mont, Lucie Salomon
    Pernes, Jean Marc
    Commeau, Philippe
    Lermusiaux, Patrick
    Leclere, Brice
    Guyomarc'h, Beatrice
    Hoffmann, Clement T.
    Maurel, Blandine
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : 447 - 457
  • [39] Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis
    Woudstra, Pier
    Damman, Peter
    Beijk, Marcel A. M.
    Grundeken, Maik J. D.
    Harskamp, Ralf E.
    Koch, Karel T.
    Henriques, Jose P. S.
    Baan, Jan, Jr.
    Vis, Marije M.
    Piek, Jan J.
    Tijssen, Jan G. P.
    de Winter, Robbert J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (01) : 26 - 33
  • [40] Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent
    Bagyura, Zsolt
    Kiss, Loretta
    Hirschberg, Kristof
    Berta, Balazs
    Szeplaki, Gabor
    Lux, Arpad
    Szelid, Zsolt
    Soos, Pal
    Merkely, Bela
    DISEASE MARKERS, 2017, 2017